Diagnosing OSA and Insomnia at Home Based Only on an Actigraphy Total Sleep Time and RIP Belts an Algorithm "Nox Body SleepTM"
Damien Leger,Maxime Elbaz
DOI: https://doi.org/10.2147/nss.s431650
2024-06-20
Nature and Science of Sleep
Abstract:Damien Leger, 1, 2 Maxime Elbaz 1, 2 1 Université Paris Cité, (VIFASOM), ERC 7330 VIgilance FAtigue SOMmeil, Paris, France; 2 Assistance Publique-Hôpitaux de Paris (APHP) Hôtel Dieu, Centre du Sommeil et de la Vigilance, Paris, France Correspondence: Damien Leger, VIFASOM Université Paris CitéCentre du Sommeil et de la Vigilance Hôtel-Dieu de Paris, 1 place du Parvis Notre Dame, Paris Cedex 04, Paris, 75181, France, Tel +33 142 34 85 63, Email Purpose: The COVID-19 pandemic has influenced clinical sleep protocols with stricter hospital disinfection requirements. Facing these new rules, we tested if a new artificial intelligence (AI) algorithm: The Nox BodySleepTM (NBS) developed without airflow signals for the analysis of sleep might assess pertinently sleep in patients with Obstructive Sleep Apnea (OSA) and chronic insomnia (CI) as a control group, compared to polysomnography (PSG) manual scoring. Patients-Methods: NBS is a recurrent neural network model that estimates Wake, NREM, and REM states, given features extracted from activity and respiratory inductance plethysmography (RIP) belt signals (Nox A1 PSG). Sleep states from 139 PSG studies (CI N = 72; OSA N = 67) were analyzed by NBS and compared to manually scored PSG using positive percentage agreement, negative percentage agreement, and overall agreement metrics. Similarly, we compared common sleep parameters and OSA severity using sleep states estimated by NBS for each recording and compared to manual scoring using Bland-Altman analysis and intra-class correlation coefficient. Results: For 127,170 sleep epochs, an overall agreement of 83% was reached for Wake, NREM and REM states (92% for REM states in CI patients) between NBS and manually scored PSG. Overall agreement for estimating OSA severity was 100% for moderate-severe OSA and 91% for minimal OSA. The absolute errors of the apnea–hypopnea index (AHI) and total sleep time (TST) were significantly lower for the NBS compared to no scoring of sleep. The intra-class correlation was higher for AHI and significantly higher for TST using the NBS compared to no scoring of sleep. Conclusion: NBS gives sleep states, parameters and AHI with a good positive and negative percentage agreement, compared with manually scored PSG. Keywords: PSG, chronic insomnia, OSA, machine learning, automatic sleep staging, artificial intelligence The use of in-laboratory polysomnography (PSG) and Home Sleep Apnea Tests (HSATs) in the diagnosis of obstructive sleep apnea (OSA) has been well defined for decades. In the last edition of the American Academy of Sleep Medicine's (AASM) technician manual, 1 and in the technical guidelines for the Evaluation, Management and Long-term Care of OSA in Adults, 2 the two accepted methods of objective testing for OSA are indeed PSG and HSAT. Furthermore, according to the Adult OSA Task Force of the AASM, HSAT may be used to diagnose OSA in patients with a high pretest likelihood of moderate to severe OSA when utilized as part of a comprehensive sleep evaluation. 2 However, HSAT testing alone is not recommended in patients with major comorbid conditions like: moderate to severe pulmonary disease, neuromuscular disease, or congestive heart failure, or those suspected of having a comorbid sleep disorder. It is less sensitive/specific than in-lab PSG, due to the lack of evaluation of total sleep time (TST), which allows calculating a real index of apnea hypopnea/hour. Using PSG for evaluating OSA involves recording the following physiological signals: electroencephalogram (EEG), electrooculogram (EOG), chin electromyogram (EMG), oronasal flow, oxygen saturation, respiratory effort, and electrocardiogram (ECG) or heart rate. Additional recommended parameters are body position and leg EMG derivations. Tibialis anterior EMG is useful in detecting leg movement and periodic limb movement disorders (PLMD), which coexist with sleep-disordered breathing (SDB) in many patients. PSG studies are usually conducted in a sleep lab facility, under the supervision of trained sleep technologists who are present throughout the study to monitor technical adequacy and patient compliance. HSAT is much simpler and less expensive than PSG. It includes at least the recording of airflow, respiratory effort, and blood oxygenation. The recommended biosensors used to monitor these parameters for HSAT are the same as for PSG: an oronasal thermal sensor to detect apnea, a nasal pressure transducer to measure hypopnea, oximetry, and calibrated or uncalibrated respiratory inductance plethysmography (RIP) for respiratory effort. The device can be self-applied by the patient. The role of a trained sleep technician technologist is also essential to app -Abstract Truncated-
neurosciences,clinical neurology